Upregulation and stabilization of senescence marker protein-30 by epigallocatechin gallate against tert-butyl hydroperoxide-induced liver injury in vitro and in vivo. 2021

Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.

Senescence marker protein-30 (SMP30), a novel ageing marker, suppresses oxidative stress in the liver. However, studies on phytochemical-mediated regulation of SMP30 expression are lacking. Here, we showed that epigallocatechin gallate (EGCg), a polyphenol abundant in green tea, positively regulates SMP30 expression in the rat hepatoma-derived Fao cells. EGCg maintained SMP30 expression even in the presence of cycloheximide, a protein synthesis inhibitor. Furthermore, treatment of cells with tert-butyl hydroperoxide (tert-BHP), an oxidative promoter, decreased SMP30 expression and ERK1/2 phosphorylation, while EGCg treatment inhibited these effects. Male mice (7-week-old) were divided into 4 groups-Control (saline), tert-BHP (1.5 mmol/kg tert-BHP), EGCg + tert-BHP (30 mg/kg/day of EGCg and 1.5 mmol/kg tert-BHP), and EGCg (30 mg/kg/day). After oral EGCg administration for 6 consecutive days, EGCg + tert-BHP group mice were administered tert-BHP. The tert-BHP-administered mice showed decreased SMP30 expression in the liver and increased aspartate aminotransferase and alanine transaminase (hepatic injury marker enzymes) activities; however, EGCg treatment attenuated these changes. Thus, EGCg-induced SMP30 upregulation may alleviate tert-BHP-induced liver injury. The findings of this study offer new perspectives of the anti-ageing properties of EGCg.

UI MeSH Term Description Entries

Related Publications

Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
January 2016, Oxidative medicine and cellular longevity,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
April 2004, Planta medica,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
March 2021, Molecules (Basel, Switzerland),
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
November 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
August 2018, Cellular reprogramming,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
July 2022, Experimental and therapeutic medicine,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
July 1986, Toxicology and applied pharmacology,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
January 1992, Free radical biology & medicine,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
July 1984, Biochimica et biophysica acta,
Hirofumi Inoue, and Kohta Arakawa, and Miori Tanaka, and Rie Katsumata-Tsuboi, and Nobuyuki Takahashi, and Mariko Uehara
October 2005, Liver international : official journal of the International Association for the Study of the Liver,
Copied contents to your clipboard!